What I do between 9:35 and 11 AM every…

support@wallstwarriors.com

Chaikin Analytics

Dear Reader, The legendary quant who built one of Wall Street’s most popular buying indicators just announced the #1 stock to buy for 2026. And for a limited time, he’s sharing this new recommendation live on-camera, completely free of charge. He spent 50 years working alongside legendary investors like George Soros, Michael Steinhardt, Steve Cohen, and Paul Tudor Jones. His work is coded into every Bloomberg terminal on Wall Street, and is still used by hundreds of banks, brokerages, and hedge funds to this day. So why is he giving away his #1 buy recommendation for FREE? It’s all comes back to a shocking new market prediction for 2026. This same legend – who accurately predicted the 2020 covid crash, the 2022 bear market, and the 2023 bank run – is now calling for an abrupt, surprising shift in the U.S. stock market. The last time this happened, average investors lost over a fifth of their portfolio in just a matter of months. So I got him to agree to an exclusive sit-down interview, where I got the whole story. You’ll get his #1 buy recommendation for 2026 when you click here. To pick these recommendations, he consulted the same system that he used when CNBC’s Jim Cramer said he’d never bet against him. So I urge you to take advantage before it’s too late. Go here now to see the names and tickers while you can. Regards, Kelly Brown Host, Chaikin AnalyticsThis ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087.

Advertising Disclosure: This email contains paid advertisements. This email is from our associates at Chaikin Analytics.Legal Entity Information: Investing Ideas Daily is owned and operated by Darwin Investor Network, a DBA of The Darwin Agency, Inc.Disclaimer: Nothing in this email should be considered personalized financial advice. Always conduct your own due diligence when investing. We urge you to read our full disclaimer by clicking on the terms of use link below.Unsubscribe: You are receiving this email as part of your complimentary subscription to the Investing Ideas Daily E-Letter. If you would like to unsubscribe, you can do so by clicking on the unsubscribe link below.Darwin Investor Network 2319 N Andrews Avenue, Fort Lauderdale, FL 33311 support@investingideasdaily.com | 1-800-496-9838Investing Ideas Daily | Privacy Policy | Terms of Use Unsubscribe | View Online

(Nasdaq: OKYO) Climbs Friday’s Watchlist (Multiple Analyst Targets –…

Any content you receive is for information purposes only. Always conduct your own research.*Sponsored(Nasdaq: OKYO) Climbs Friday’s Watchlist (Multiple Analyst Targets – Bullish Technicals)*Click Here To Get Our Alerts Faster Via SMS* January 23rdDear Reader, A clinical-stage biopharma company is tackling one of medicine’s most persistent challenges—developing treatments that address both the symptoms and underlying causes of eye and inflammatory diseases. With a strong scientific foundation and an ambitious clinical roadmap, this organization is translating breakthrough discoveries into targeted therapies designed to improve patients’ daily lives. Its work bridges academic innovation and real-world medical need, setting a pace that few in the space are matching. This could be one of those rare opp’s where meaningful science meets significant global impact. And with multiple bullish technicals, strong analyst targets, a key inside share purchase, and relatively low float, this under-the-radar Nasdaq idea tops our watchlist: OKYO Pharma Limited (Nasdaq: OKYO) OKYO Pharma Ltd. is a biopharmaceutical company dedicated to developing an innovative treatment for neuropathic corneal pain and dry eye disease. The company aims to provide targeted therapy that not only alleviates pain but also controls inflammation, while enhancing ocular residence time for more effective, lasting relief. And based on 5 potential catalysts, (Nasdaq: OKYO) has risen to the top spot on my watchlist. Check them out: No. 1 – At Least 3 Analyst Targets Are Suggesting OKYO To Have Triple-Digit Upside Potential! No. 2 – A Multitude Of Bullish Technical Indicators Surround OKYO Across 3 Separate Terms. No. 3 – An Insider Purchase Could Raise Eyebrows That Company Confidence Is Brimming. No. 4 – Promising Data Shows Urcosimod May Help Restore Corneal Nerve Structure In Patients With NCP. No. 5 – With A Relatively Low Float, Volatility Potential Could Be Heightened (Daily). But more on those in a second…Neuropathic Corneal Pain (NCP) NCP is a severe, chronic, and debilitating disease for which there are no approved commercial treatments currently available. Current treatments are limited to short term NSAIDs, steroids, and opioids in severe cases. Side effects and the risk of addiction to o-p-ioids is a serious concern. Often underdiagnosed, as the symptoms can overlap with other eye conditions, and treatment can be difficult to manage effectively. ChemR23 receptor on leukocytes targeted by urcosimod is also expressed on neurons and glial cells in the dorsal root ganglion and spinal cord. Topical administration of urcosimod was effective in suppressing corneal pain in a ciliary nerve ligation mouse model of NCP similar to that of gabapentin, a commonly used oral drug for neuropathic pain, given by intraperitoneal injection. The pain-relieving potential of urcosimod is very important because a considerable number of dry eye patients with chronic inflammation also suffer from ocular pain. Urcosimod (formerly called OK-101) Drug Candidate Urcosimod is a novel class of chemerin (ChemR23 or CMKLR1) receptor agonist that produces an anti-inflammatory and reduction in neuropathic pain. The chemerin receptor is a G protein-coupled receptor (GPCR) found on select immune, epithelial, and dorsal root ganglion/spinal cord neuronal cells. Activation of chemerin receptor has been shown to modulate the resolution of inflammation and neuropathic pain. Urcosimod can potentially benefit patients suffering from ocular pain and ocular inflammation. Dry Eye Dry Eye affects over 35% of the population aged 50+, with women representing approximately two-thirds of those affected. Worldwide, ~700Mn patients suffer from dry eye disease. Several side effects and modest efficacy of currently available drugs demand new therapies to treat dry eye disease. Huge potential for new drugs for a $5Bn dry eye market.—– Phase 2 NCP Clinical Trial Demonstrated Promising Drug Effect Phase 2, Randomized, Double Masked, Placebo-Controlled Study Assessing Safety and Efficacy for Urcosimod in Subjects with NCP STUDY RESULTS After 12 weeks of treatment, 75% of per-protocol patients receiving urcosimod (0.05%) showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. The urcosimod (0.05%) group showed a mean pain score improvement of 5.5 points on a 10-point VAS, compared with a mean improvement of 2.75 points for placebo. Urcosimod (0.05%) demonstrated a marked reduction in pain scores as early as Week 4, with sustained efficacy maintained throughout the trial. Notably, all these responders entered the study with moderate to severe NCP pain scores despite prior use of maximum medical therapy. No serious adverse events were reported among the 18 patients throughout the trial. PipelineSources: OKYO Website. OKYO Presentation.—– And mentioned above, (Nasdaq: OKYO) has several potential catalysts to consider focusing on. Check them out: No. 1 OKYO Potential Catalyst – At Least 3 Analyst Targets Are Suggesting OKYO To Have Triple-Digit Upside Potential! Take a look at this…That’s right. At least different analyst targets are suggesting OKYO to have triple-digit upside potential from Thursday’s closing valuation. More specifically: H.C. Wainwright & Co.’s $7 target suggests 175+% potential upside. Lucid Capital Markets’ $13 target suggests over 400% potential upside. And B. Riley Securities $5 target suggests more than 100% potential upside Take a moment to click the picture above and get a look at all 3 reports.—– No. 2 OKYO Potential Catalyst – A Multitude Of Bullish Technical Indicators Surround OKYO Across 3 Separate Terms. On Thursday at 4:00PM EST, Barchart was reporting several triggered technical indicators indicators across the short, medium, and long term for OKYO. Here’s their list (as of 4:00PM EST Thursday): Short Term Indicators 20 Day Moving Average20 – 50 Day MA Crossover20 – 100 Day MA Crossover20 – 200 Day MA Crossover Medium Term Indicators 50 Day Moving Average Long Term Indicators 100 Day Moving Average200 Day Moving Average100 – Day MA Crossover Make sure to watch these technical indicators closely moving forward.—– No. 3 OKYO Potential Catalyst – An Insider Purchase Could Raise Eyebrows That Company Confidence Is Brimming. OKYO Pharma Announces Chairman and Founder Acquires Shares LONDON and NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, today announces it has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 24,551 of the Company’s ordinary shares on NASDAQ, bringing his total holding to 10,516,297 shares. Read the full article here.—– No. 4 OKYO Potential Catalyst – Promising Data Shows Urcosimod May Help Restore Corneal Nerve Structure In Patients With NCP. OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain Patients treated with 0.05% urcosimod demonstrated directionally favorable improvements in nerve fiber count and fiber length, trends not observed in the placebo group These findings suggest that urcosimod may have a positive impact on corneal nerve health in patients with neuropathic corneal pain Corneal nerve imaging data from the Phase 2 NCP trial were analyzed using in vivo confocal microscopy LONDON and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, is pleased to announce new analyses of corneal images from the recently completed placebo-controlled, randomized, double-masked, Phase 2 clinical trial of urcosimod in neuropathic corneal pain (NCP). Patients treated with 0.05% urcosimod demonstrated not only a positive reduction in neuropathic corneal pain, but also favorable changes in corneal nerve structure which were not observed in the placebo group. … “These results provide early evidence that urcosimod may help restore corneal nerve structure in patients suffering from neuropathic corneal pain,” said Raj Patil, PhD, Chief Scientific Officer of OKYO Pharma. “While exploratory, these findings reinforce our long-standing belief that targeting the chemerin receptor pathway may open a new therapeutic avenue for patients with neuropathic corneal pain. We are encouraged by the biological activity observed and believe they provide an important foundation for the continued development of urcosimod.” Read the full article here.—– No. 5 OKYO Potential Catalyst – With A Relatively Low Float, Volatility Potential Could Be Heightened (Daily). According to info from the Yahoo Finance website, OKYO has a relatively low float. The website reports this profile to have roughly 22.47Mn shares in its float. Why is that important? It’s important on one crucial level. Volatility potential. If the company provides positive news at the beginning of 2026, could it help provide a breakout spark when paired with this volatility potential?—– (Nasdaq: OKYO) Recap – 5 Potential Breakout Catalysts Lead The Way! No. 1 – At Least 3 Analyst Targets Are Suggesting OKYO To Have Triple-Digit Upside Potential! No. 2 – A Multitude Of Bullish Technical Indicators Surround OKYO Across 3 Separate Terms. No. 3 – An Insider Purchase Could Raise Eyebrows That Company Confidence Is Brimming. No. 4 – Promising Data Shows Urcosimod May Help Restore Corneal Nerve Structure In Patients With NCP. No. 5 – With A Relatively Low Float, Volatility Potential Could Be Heightened (Daily).—– Coverage is now officially kicked-off on OKYO Pharma Limited (Nasdaq: OKYO). Be ready for updates coming your way soon. Sincerely,FierceAnalyst | Jaks SwiftEditorial Writer (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.) *FierceInvestor (FierceInvestor . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and FierceInvestor (“FI”) is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors. Pursuant to an agreement between SWN Media LLC and TD Media LLC, SWN Media LLC has been hired for a period beginning on 01/22/2026 and ending on 01/23/2026 to publicly disseminate information about (OKYO:US) via digital communications. Under this agreement, SWN Media LLC has been paid seventeen thousand five hundred USD (“Funds”). To date, including under the previously described agreement, SWN Media LLC has been paid thirty five thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither SWN Media LLC, TD Media LLC and their member own shares of (OKYO:US). Please see important disclosure information here: https://fierceinvestor.com/disclosure/okyo-7qjxm/#details

Fierce Investor | 4834 NW 2nd Ave Unit #388 | Boca Raton, FL 33431 USUnsubscribe | Update Profile | Constant Contact Data Notice

Heads Up: See Why (USAU) Just Landed On This…

Any content you receive is for information purposes only. Always conduct your own research. *Sponsored Krypton Street Just Announced (USAU) Is Topping Our Watchlist  This Morning—Friday, January 23, 2026.Don’t Miss The Next Breakout—Get Real-Time Alerts Sent Directly To Your Phone. Up To 10X Faster Than Email.(USAU) Comes Backed With 8 Potential Catalysts  We’re Tracking Right Now Take A Look At (USAU) While It’s Still Early… January 23, 2026 Heads Up | See Why (USAU) Just Landed On This Morning’s Early RadarDear Reader,While the broader markets grapple with significant macroeconomic shifts, a quiet powerhouse in the American mining sector is positioning itself to capitalize on what many experts believe is a generational bull run in precious metals.U.S. Gold Corp. (Nasdaq: USAU) stands out as a rare, fully permitted, shovel-ready project in North America at a time when global gold prices have recently tested all-time highs of $4,888.With a remarkably tight share structure and a massive $31.2M private placement recently closed, this company is moving into early 2026 with the wind at its back and a clear path toward production.And that’s just one of the reasons why U.S. Gold Corp. (Nasdaq: USAU) is topping our watchlist this morning—Friday, January 23, 2026.But keep in mind, (USAU) has less than 12M shares available to the public. When companies like this have small floats, the potential exists for big moves as demand begins to shift.Recently, (USAU) showed what that can look like.(USAU) made an approximate 60% move in just over a month, from $14.53 on November 20 to $23.44 on December 23.One firm has been increasingly bullish on USAU. H.C. Wainwright & Co. recently raised its target from $22 to $27.50, which suggests a 43% upside potential from its recent $19.22 range.Technical indicators from Barchart also show (USAU) is currently trending above every major moving average that it tracks, including the 5-day, 20-day, 50-day, 100-day, and 200-day, which could indicate the potential for continued momentum as the company enters 2026.Institutional interest has reached record levels for the company, with over 20% of the company owned by institutions and hedge funds. Prominent names such as Franklin Templeton, Mackenzie, and Eric Sprott have participated in recent rounds.This institutional backing serves as a significant de-risking signal, suggesting that professional capital managers have thoroughly vetted the company’s engineering and management.What comes next is where the story could get even more exciting: (USAU) isn’t a one-asset headline—it’s a U.S.-based platform with multiple shots on goal and a flagship project that’s already cleared major hurdles.And as the calendar flips deeper into 2026, the company’s location, asset mix, and near-term potential milestones are lining up in a way that’s hard to ignore.The Strategic Hub of American Mining U.S. Gold Corp. (Nasdaq: USAU) is a U.S.-focused gold and copper exploration and development company with a diversified portfolio of high-potential assets. The company’s flagship is the CK Gold Project located in Southeast Wyoming, a project that has already undergone a rigorous Preliminary Feasibility Study (PFS).Beyond Wyoming, the company maintains a strategic foothold in the nation’s most prolific mining trends, including the Keystone property on Nevada’s Cortez Trend and the Challis Gold Projectin Idaho.What distinguishes (USAU) from its peers is its advanced developmental status. Unlike many junior mining firms that remain years away from breaking ground, (USAU) received its final non-conditional permit to mine at the CK Gold Project in late 2024. This status places the company in an elite category of “shovel-ready” projects in North America.The company is currently finalizing its Definitive Feasibility Study (DFS), which is expected to be released in early 2026, providing the final economic blueprint for construction.The 2026 Gold Supercycle The macro environment for U.S. Gold Corp. (Nasdaq: USAU) is currently characterized by a powerful alignment of institutional demand and technical strength.As of January 22, 2026, gold is trending near $4,827 per ounce, following a massive 65% surge in 2025. Institutional sentiment is reaching a fever pitch; Goldman Sachs recently raised its 2026 price target to $5,400, citing central bank buying and private-sector diversification.Major institutions like UBS and JPMorgan Chase are forecasting prices exceeding $5,000 in the near term.This rising tide significantly elevates the economics of the CK Gold Project, which was originally modeled at much lower metal prices.At current levels, the project’s estimated 750K ounces of gold equivalent could be valued at approximately $3.4B, providing a massive disparity compared to the company’s current market valuation.The CK Gold Project: A Deep Dive into Reserves The flagship CK Gold Project is more than just a resource on paper; it is a de-risked asset located in a top-tier mining jurisdiction. According to the January 2026 Corporate Presentation, the project hosts proven and probable mineral reserves of 1.67M gold equivalent ounces.This mineral wealth is composed of approximately 70% gold and 30% copper, offering investors exposure to two of the most critical metals for the modern economy.Executive Chairman Luke Norman has highlighted that 80% of the holes drilled at CK Gold have bottomed in mineralization. This suggests the potential to bring another million ounces into the project.In the world of mining, adding 1M ounces to a project of this scale could represent an additional $1B in Net Present Value (NPV). The project is designed as a low-strip, surface deposit, which keeps operational complexity and costs significantly lower than underground alternatives.Infrastructure: The Wyoming Advantage One of the most underappreciated aspects of (USAU) is its logistical superiority. Located just 20 miles outside of Cheyenne, Wyoming, the CK Gold Project sits on the doorstep of a major employment hub.Unlike remote operations in Alaska or the Andes, workers can commute daily, eliminating the need for expensive “man camps” and complex fly-in-fly-out logistics.The site is also near the Interstate 80 corridor and Union Pacific rail lines, making the transport of equipment and mineral concentrates remarkably efficient.Power infrastructure is already being addressed through a local utility substation connection, which allows the company to avoid the massive capital expenditure of building its own power lines—a rare advantage that preserves treasury funds for development.Technological Innovation and Cost Control To further enhance the project’s economics, USAU is incorporating advanced technologies into its Definitive Feasibility Study. The company has adopted Glencore’s Jameson cell flotation technology, which offers improved recovery rates within a smaller footprint, thereby reducing both capital and power costs.Additionally, the team has optimized tailings management by switching to a continuous belt filter system. These technical refinements are intended to offset inflationary pressures on labor and materials, ensuring that the project remains highly profitable even in fluctuating market conditions.The All-in Sustaining Costs (AISC) were recently estimated at $937 per gold equivalent ounce, which is far below the current spot price, highlighting the project’s high-margin nature.The Path to 2028 Production Management’s roadmap is clear and focused on execution. Following the publication of the DFS in the first quarter of 2026, (USAU) plans to finalize construction financing in the first half of the year.The company is exploring multiple avenues, including traditional debt, vendor financing, and offtake agreements for its copper-gold concentrate.With an 18-month runway from development to production, the company is targeting commercial production by 2028. The initial mine life is slated for 10 years, producing roughly 110K gold equivalent ounces annually.However, the district-scale potential of the Wyoming asset, combined with the “blue sky” upside of the Keystone Project in Nevada, suggests that (USAU) is building for a much longer operational horizon.Management’s Proven Track Record The team leading U.S. Gold Corp. (Nasdaq: USAU) has deep experience in bringing large-scale mines online. CEO George Bee brings over 16 years of experience from Barrick Gold, where he held senior roles at world-class operations like Goldstrike and Veladero.This level of technical expertise is critical as the company transitions from a developer to an operator.Complementing him is Executive Chairman Luke Norman, who has raised in excess of $300M for resource ventures throughout his career, ensuring the company remains well-funded through its development milestones.8 Reasons Why (USAU) Is Topping Our Watchlist This Morning —Friday, January 23, 2026… 1. Small Float: With less than 12M shares available to the public, (USAU)’s small float could witness the potential for big moves if demand begins to shift.2. Recent Momentum: Over a little more than one month, (USAU) made an approximate 60% move, from about $14.53 to roughly $23.44, demonstrating how quickly sentiment can shift around the name.3. Analyst Coverage: H.C. Wainwright recently raised their target on (USAU) from $22 to $27.50, which suggests over 40% upside potential from recent levels, highlighting a clear valuation gap.4. Technical Trends: With Barchart showing (USAU) currently trending above every major moving average it tracks, the chart is signaling a broad, aligned uptrend heading into 2026.5. Massive Institutional Backing: Recent $31.2M financing from institutional heavyweights like Franklin Templeton validates the company’s project economics.6. Fully Permitted Status: (USAU) holds a final, non-conditional permit to mine in Wyoming, placing it in a rare category of shovel-ready North American assets.7. Record Gold Prices: With gold recently hitting $4,888 and Goldman Sachs targeting $5,400, (USAU)’s 1.7M ounce reserve is more valuable than ever.8. Upcoming DFS Catalyst: The release of the Definitive Feasibility Study in early 2026 is a major expected fundamental re-rating event.Take A Look At (USAU) While It’s Still Early… As you can see, (USAU) checks a rare mix of boxes at the same time: a tightly held share base, recent momentum, and a technical picture that Barchart shows trending above key moving averages.Add in a $31.2M raise that brought in well-known institutions, plus a final, non-conditional mining permit in Wyoming, and you’re looking at a company with real milestones ahead—not just a story.With gold in the high-$4,800s recently and major banks projecting higher levels into 2026, the setup around (USAU) and its reported ~1.7M AuEq reserve could start drawing more attention across the space.And with the Definitive Feasibility Study expected in early 2026, there’s a clear next checkpoint that could reshape how the market frames the project.We have all eyes on (USAU) this morning.Take a look at (USAU) while it’s still early.Also, keep a lookout for my next update, it could be coming to you within the next hour.Sincerely,Alex Ramsay Co-Founder / Managing Editor Krypton Street Newsletter KryptonStreet.com (“KryptonStreet” or “KS” ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KS is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.Pursuant to an agreement between Media 1717 LLC and TD Media LLC, Media 1717 LLC has been hired for a period beginning on 01/22/2026 and ending on 01/23/2026 to publicly disseminate information about (USAU:US) via digital communications. Under this agreement, Media 1717 LLC has been paid six thousand five hundred USD (“Funds”). To date, including under the previously described agreement, Media 1717 LLC has been paid thirteen thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.Neither Media 1717 LLC, TD Media LLC and their member own shares of (USAU:US).Please see important disclosure information here: https://kryptonstreet.com/disclosure/usau-dBaCX/#details

Media 1717 LLC | 6586 W Atlantic Ave, Unit #2086, Delray Beach, FL 33446UnsubscribeUpdate Profile | Constant Contact Data NoticeSent by alex@kryptonstreet.com

🗞️ Today’s top 5 featuring: Countries participating in Trump’s…

͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ January 23, 2026top newshealthbusinessentertainmentcoronavirusTOP NEWS Countries participating in Trump’s ‘Board of Peace’ announcedU.S. President Donald Trump officially launched the “Board of Peace” during the World Econ…READ RUNDOWNTrump proposes new tariffs in effort to acquire GreenlandDuring a recent event at the White House, President Donald Trump discussed his potential u…READ RUNDOWNHEALTH Why do some people get bad colds while others don’tA recent study published in the journal Cell Press Blue highlights the critical role of th…READ RUNDOWNBUSINESS Trump files $5 billion lawsuit against JPMorgan and CEO Jamie DimonPresident Donald Trump has initiated a lawsuit against JPMorgan Chase and its CEO, Jamie D…READ RUNDOWNENTERTAINMENT Elon Musk predicts retirement saving will become ‘irrelevant’ in 20 yearsDuring a recent news conference in the Oval Office, Elon Musk, CEO of Tesla and SpaceX, ma…READ RUNDOWNThe Press Rundown128 Sunset Blvd #1283 New Castle, DE 19720 United States Manage Email Preferences  Unsubscribe

Nasdaq Brings 0DTE to Big Stocks: AAPL, TSLA, NVDA,…

Hey, it’s Don.Monday opens a new chapter in options trading.Nasdaq is bringing Monday, Wednesday, and Friday expirations to Tesla, NVIDIA, Apple, Amazon, Meta, Broadcom, Alphabet, and Microsoft.Zero DTE on individual stocks. Three times a week. Every week.This is the biggest expansion of short-term options since they launched daily expirations on SPX.Billions of dollars already flow through 0DTE options every single day. Now that firepower spreads across three weekly expirations in the biggest names on the planet.I’ve been doing this for over 20 years. I’m not going to lie… I’m drooling over the opportunities here.But most retail traders? They’re about to get chopped up.Here’s what they don’t understand…Market makers price options using exact probability models. They know the odds on every trade before you click the button.When you understand those same models, you stop guessing. You start seeing what they see.That’s what I’m teaching tomorrow.I just kicked off an educational series on probability-based trading that continues today. This is the same framework I’ve used for two decades. And it translate today’s market in ways you’ve never seen before.And here’s how to do it for less than it would cost you to buy a cup of coffee.Our 3 Trade Micro-Challenge lets you name your own price for your first 30 days.You get my live morning sessions, real-time trade alerts, our VIP chatroom, and complete options training.The kind of education that used to cost thousands… today you can get in for less than a cup of coffee.JOIN THE 3 TRADE MICRO-CHALLENGE HERESee you in the room.—DonHelping You Become a Better Trader…it’s What We Do. Experience TheoTrade® Today!Whether you are a beginning, intermediate, or active trader, you will find a treasure chest of valuable trading education resources, both free and paid, that will help take your trading to the next level. We are committed to helping you become the best trader you can be.Disclaimer: Neither TheoTrade.com  or any of its officers, directors, employees, other personnel, representatives, agents or independent contractors is, in such capacities, a licensed financial adviser, registered investment adviser, registered broker-dealer or FINRA |SIPC |NFA-member firm. TheoTrade does not provide investment or financial advice or make investment recommendations. TheoTrade is not in the business of transacting trades, nor does TheoTrade agree to direct your brokerage accounts or give trading advice tailored to your particular situation. Nothing contained in our content constitutes a solicitation, recommendation, promotion, or endorsement of any particular security, other investment product, transaction or investment.Trading Futures, Options on Futures, and retail off-exchange foreign currency transactions involves substantial risk of loss and is not suitable for all investors. You should carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources. You may lose all or more of your initial investment. Opinions, market data, and recommendations are subject to change at any time. Past Performance is not necessarily indicative of future results.TheoTradePO Box 24790 Christiansted, Virgin Islands 00824 1 (800) 256-8876support@theotrade.comWant to change how you receive these emails? You can Update your preferencesTheotrade.com  |  Privacy Policy

LMND Hits 52-Week High After Tesla Insurance Launch

UnsubscribeBREAKING: 4,400 Starlink satellites repositioned – why now? (From Behind the Markets)Lemonade’s Tesla Deal Could Rewrite How Auto Insurance Is PricedWritten by Jeffrey Neal Johnson on January 22, 2026 In BriefLemonade’s new autonomous car insurance product leverages direct integration to offer discounts for miles driven in full self-driving mode.Management reported a historic low gross loss ratio and a second consecutive quarter of positive adjusted free cash flow in the recent earnings report.Institutional confidence is rising as a banking giant recently disclosed a passive stake in the company to support long-term growth plans.Lemonade Inc. (NYSE: LMND) shares hit a new 52-week high of $85.29 on Jan. 21, 2026, closing the session up over 9%. The rally was driven by volume of 2.64 million shares, higher than the average, indicating strong investor interest. This upward movement follows the company’s announcement of a technical collaboration with Tesla (NASDAQ: TSLA) to launch Lemonade Autonomous Car Insurance.The new product introduces a pricing model that offers a 50% discount per mile driven while Tesla’s Full Self-Driving (FSD) capability is engaged. This marks a pivotal moment for the insurtech company, which has seen its stock price climb nearly 20% since the start of the year.The market has reacted to this news as more than just a product launch; it is being viewed as a significant validation of Lemonade’s technology-first business model. By directly linking insurance premiums to the use of autonomous driving software, Lemonade is positioning itself at the forefront of a shift in the auto industry. Investors are currently betting that this data-driven approach will allow the company to capture market share from traditional insurers while maintaining healthy profit margins.7 High-Yield Dividend Stocks You Need to See (Ad)7 High Yield Dividend Stocks to Buy Now 💰 Love steady payouts? This free report reveals 7 high-yield dividend stocks you need to know about. From Company #3, a tobacco giant innovating with smokeless products, to Company #4, famously known as “The Monthly Dividend Company,” these picks deliver steady income you can count on.Perfect for income-focused investors.How Real-Time Data Changes the Profit EquationThe core of this new collaboration is an API integration, a software connection that allows Lemonade’s systems to talk directly to a customer’s Tesla. This technology enables the insurer to distinguish between miles driven by a human and miles driven by the vehicle’s autonomous software.This distinction allows for real-time risk pricing. Traditional insurers like Allstate (NYSE: ALL) or Progressive (NYSE: PGR) rely heavily on proxies to guess how safe a driver might be. They use data points such as credit scores, age, zip codes, and marital status. In contrast, Lemonade is pricing risk based on actual behavior and technology usage. If the data proves that FSD is safer than a human driver, Lemonade can offer lower rates without sacrificing its own profit margins.The Economic Advantage: Why This MattersBeyond the technology, this deal offers a significant financial advantage: Negative Customer Acquisition Cost (CAC). In the insurance world, acquiring a new customer is incredibly expensive.Ending the Ad War: Legacy carriers spend billions annually on television commercials (think geckos and emus) to fight for market share. By integrating directly into the Tesla ecosystem, Lemonade can access a large pool of drivers without paying for expensive mass-media advertising.High-Value Demographics: Tesla owners historically represent a desirable demographic for insurers. They often have higher credit scores and drive newer vehicles equipped with advanced safety features. These drivers tend to file fewer claims.The Bundle Effect: Once a driver signs up for auto insurance, Lemonade can cross-sell its Home, Pet, and Life insurance products. This increases each customer’s lifetime value (LTV) while keeping acquisition costs low.By targeting a specific, tech-savvy niche, Lemonade aims to bypass the costly customer-acquisition battles that plague the rest of the industry.Buy. Hold. Relax. These 10 Stocks Could Build Your 2030 Wealth (Ad)Tired of chasing the market every week? Our new free report reveals 10 U.S. stocks you can confidently buy now and hold long term — handpicked by a veteran investor with over 20 years of experience and backed by deep research into megatrends like AI, EVs, and cloud tech.Click here to get the 10 Stocks to Buy and Hold — free for a limited timeHow Improved Margins Enabled the Tesla PivotTwo years ago, launching a risky new product with deep discounts might have unsettled investors. However, Lemonade is approaching this expansion from a position of improved financial stability. The company’s third-quarter 2025 earnings report provided the data necessary to support this aggressive strategy.Revenue for the quarter grew 42% year-over-year to $194.5 million, showing that demand for Lemonade’s products remains strong. More importantly, the company has made significant progress in its underwriting discipline.The most critical improvement is in the company’s efficiency metrics:Gross Loss Ratio (GLR): This metric measures the percentage of premium dollars paid out in claims. A lower number is better because it means the company keeps more money. Lemonade reported a GLR of 62% in Q3 2025, a historic low for the company. This is a massive improvement from previous years, when ratios hovered in the 70s or 80s, proving that their algorithms effectively identify and price risk.Cash Flow Positive: Perhaps the most bullish signal is the cash flow. Lemonade achieved a positive Adjusted Free Cash Flow of $18 million in the third quarter. This was the second consecutive quarter of positive cash generation.These numbers indicate that the business is becoming self-sustaining. Lemonade is no longer burning cash just to keep the lights on. This financial health gives management the freedom to invest in growth initiatives, such as the Tesla partnership, without taking on new debt or diluting shareholders by selling more stock.The Tug-of-War: Bulls, Bears, and Execution RisksThe stock’s recent performance reflects a fierce battle between institutional confidence and short-seller skepticism. This dynamic creates a volatile but potentially lucrative environment for investors.On the bullish side, smart money is increasing its exposure. JPMorgan Chase recently disclosed a 5.9% passive stake in Lemonade, purchasing approximately 4.5 million shares. When a banking giant like JPMorgan (NYSE: JPM) acquires a significant stake in a company, it often signals to the broader market that the stock has long-term potential. Additionally, Lemonade’s founders, Daniel Schreiber and Shai Wininger, have previously purchased shares on the open market, aligning their personal financial interests with those of the shareholders.The Short Squeeze PotentialDespite the positive momentum, skepticism remains high. Approximately 20% of Lemonade’s floating shares are currently sold short.What is Short Selling? Short sellers are traders who borrow stock and sell it, betting that the price will go down so they can repurchase it at a lower price later.The Squeeze: When a stock with high short interest receives good news (like the Tesla partnership), the price jumps. Short sellers begin losing money rapidly. To stop the bleeding, they must buy shares to close their positions. This buying pressure forces the price even higher, creating a feedback loop known as a short squeeze.Execution Risks RemainInvestors must remain balanced. While the stock is rallying, the rollout is currently limited to Arizona and Oregon. Scaling this product across all 50 states requires navigating a complex web of regulatory approvals, which could slow down growth. Furthermore, the entire premise of the 50% discount relies on Tesla’s FSD being safer than human drivers. If accident rates for FSD users rise, Lemonade could face higher-than-expected claims costs, which would hurt the profit margins they have worked hard to improve.Can AI Finally Disrupt Auto Insurance?Lemonade has successfully transitioned from a concept stock into a fundamental disruptor with improving margins and steady growth. The partnership with Tesla places significant pressure on legacy carriers to modernize their own pricing models or risk losing their safest and most profitable drivers to tech-forward competitors.While risks regarding regulatory expansion and autonomous safety performance remain, the market’s reaction suggests that investors are waking up to the viability of AI-driven insurance. The stock’s performance in 2026 will likely depend on Lemonade’s ability to execute this rollout smoothly while maintaining the financial discipline shown in recent quarters.Read this article online ›Recommended StoriesQualcomm Gets Crushed: $150 Is the Level to Watch Going Forward[URGENT!] SpaceX Going Public! – Pre-IPO Action! (From Paradigm Press)Halliburton Beat Expectations Again—Now the Rebound Trade Gets RealTrump Did WHAT?? (From The Oxford Club)Credo Just Pulled Back—This Might Be the Cleanest Entry PointCash Is King: DigitalBridge Is the Ultimate Defensive PlayWhy Taiwan Semiconductor and Meta Could Be the Hidden Bull Case for Broadcom  Did you find this article useful?     Thank you for subscribing to MarketBeat! We empower individual investors to make better investment decisions by offering up-to-the-minute financial information and best-in-class investment research. If you have questions or concerns about your account, please contact MarketBeat’s U.S. based support team at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. Copyright 2006-2026 MarketBeat Media, LLC. All rights reserved. 345 N Reid Pl., Sixth Floor, Sioux Falls, SD 57103-7078. United States..From Our Partners: This is the Exact Moment the AI Boom Will End (From Trend Labs)

I’m a Futurist: Here are 3 stocks better than…

I’m a Futurist: Here are 3 stocks better than NvidiaNvidia’s own customers could soon become fierce competitors, dethroning the AI Chip King. But there’s a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry’s “Nvidia-killer” stock ideas.Click here for complete analysis.

Stockguru LLC (dba InvestingDistrict), 2563 cherry hill ln, Hermitage, PA 16148, United StatesYou may unsubscribe or change your contact details at any time.

The $1 “Robot Revolution” Stock

You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from Immersed Inc. Have you heard about the tiny sub-$1 company gearing up for the Humanoid Robotic Revolution?They’re capturing the essential spatial data robots need to operate like humans – data no one else has figured out how to gather at scale.It’s powered by their new device, Visor, a breakthrough spatial-computing headset that trains AI by showing how real people work, move, and interact in 3D space.While everyone focuses on chatbots, this company is preparing for the next wave:AI + Robotics + Human-Level Spatial IntelligenceThere’s a little-known way investors can still get in for under $1/share.If you believe robotics will transform the next decade… you’ll want to see this.Go Here to Secure your Shares 👉DisclosuresThis Reg CF offering is made available through DealMaker Securities LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. This Reg CF offering is made available through DealMaker Securities LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security.We would like to inform you that this is a paid advertisement for Immersed Reg CF offering and we have received or expect to receive compensation in connection with the disbursing this communication for Immersed. The compensation could consists of $1,000 or more and was received/will be received from Investing Media Solutions.This communication should not be considered as an endorsement of Immersed and we are not responsible for any errors or omissions in any information provided about by or about Immersed.We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions.This disclosure is made as of 01/23/2026.Our mailing address is:  Behind the Markets, LLC  4260 NW 1st Avenue, Suite 55  Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved.  You’re receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices. Behind the Markets You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. Today’s Bonus Content: Three New AI Plays for the FASTEST Gains You’ll Ever See(When you click the link, your email address will automatically be added to Jeff’s guest list.)

🐤 US futures slip and world shares are mixed…

UnsubscribeFRIDAY, JANUARY 23rdGOOD MORNINGU.S. markets were digesting fresh economic data that could influence the Fed’s path. The Commerce Department said the Fed’s preferred inflation gauge, the PCE price index, ticked up to 2.8% year-over-year in November (core also 2.8%), while consumer spending stayed healthy. Weekly jobless claims inched up to 200,000 but remain historically low, suggesting labor-market resilience even as inflation shows persistence. Corporate headlines added stock-specific pressure. Paramount extended its hostile $77.9 billion takeover tender for Warner Bros. Discovery, moving the offer deadline to Feb. 20 while keeping the $30-per-share cash price and signaling a forthcoming proxy fight. Political and legal noise also surfaced as former President Trump said he is suing JPMorgan Chase and CEO Jamie Dimon, a development investors will watch for potential reputational or regulatory fallout for big banks. NYC nurses resumed strike talks on day 11, creating operational risks for major hospital systems. Commodities and futures were mixed: gold futures rose, lumber and copper showed modest moves, and corn and wheat traded higher, all factors investors consider for inflation and sector rotation. Markets remain sensitive to macro prints and headline risk heading into earnings season.Featured: 5 Stocks Under $5 with Big Potential (Ad)AUTO/TIRES/TRUCKSTesla’s Robotaxi Goes Unsupervised: Is the Rally Justified?For years, the promise of self-driving cars has fueled Tesla’s (NASDAQ: TSLA) massive stock valuation. That promise has transitioned from a theoretical concept to a physical reality on public roads. On Thursday, Jan. 22, Tesla officially confirmed the launch of unsupervised Robotaxi rides in…READ THE FULL STORYFROM OUR PARTNERSQuiet Moves in Key Sectors Suggest New Momentum Is BuildingSmall Caps Are Moving First as Sectors Shift Fierce Investor tracks the early tremors inside emerging sectors where momentum often starts. Get alerts built around real-time shifts—not hype cycles.JOIN FREE — START TRACKING NEW SECTOR MOVESTRANSPORTATIONUAL Stock Taking Flight After Earnings Confirm Strong DemandUnited Airlines (NASDAQ: UAL) stock is up more than 2% after the company delivered its fourth-quarter earnings report for 2025. Despite headwinds from the November government shutdown, United posted record revenue, spurred by strong demand from higher-income and corporate travelers. Revenue came …READ THE FULL STORYTECHNOLOGYWhy Apple’s Sell-Off May Be Overdone Right Before EarningsShares of tech giant Apple Inc. (NASDAQ: AAPL) have been under pressure, as investors continue to sell off the stock. With shares currently trading around $245, they are down close to 15% from the all-time high set just last month. The drop has been mostly one-directional and not a little surpri…READ THE FULL STORYFROM OUR PARTNERS[URGENT!] SpaceX Going Public! – Pre-IPO Action!A growing number of investors are paying attention to developments around private space companies and potential future public listings. In a recent briefing, one research publisher outlines how some investors are seeking early exposure to the space economy through publicly traded assets — without waiting for a formal IPO. The presentation walks through the structure, risks, and mechanics behind this approach for those who want to understand how it works.READ THE FULL SPONSOR BRIEFING HERETECHNOLOGYQualcomm Gets Crushed: $150 Is the Level to Watch Going ForwardShares of Qualcomm Inc (NASDAQ: QCOM) have been hit hard over the past week, sinking roughly 17% across seven consecutive sessions with little resistance from the bulls. The tech giant has now effectively given up all its gains from 2025 and is trading back near levels it was at in 2020, a sobe…READ THE FULL STORYENERGYHalliburton Beat Expectations Again—Now the Rebound Trade Gets RealHalliburton’s (NYSE: HAL) stock price has been in a correction for over 18 months, setting up its next big move. That movement is upon us. The company’s latest earnings results, while tepid in regard to growth, have consistently outperformed expectations, enabling robust capital return…READ THE FULL STORYFROM OUR PARTNERSMy Best Trade Idea for 2026: 24-Hour FortunesForget self-driving cars, robots, or AI agents.  This coming Wednesday, January 28, at 8 p.m. ET… Jeff Brown will tell you about a new AI application so powerful that it has been delivering gains big enough to turn $10,000 into… $101,700… $151,600, and even a mind-blowing $650,000… all in a 24-hour period.CLICK HERE TO SAVE YOUR SEAT FOR THIS SPECIAL STRATEGY SESSION HE’S CALLING 24-HOUR AI FORTUNES.FINANCELemonade’s Tesla Deal Could Rewrite How Auto Insurance Is PricedLemonade Inc. (NYSE: LMND) shares hit a new 52-week high of $85.29 on Jan. 21, 2026, closing the session up over 9%. The rally was driven by volume of 2.64 million shares, higher than the average, indicating strong investor interest. This upward movement follows the company’s announcement of a tec…READ THE FULL STORYTECHNOLOGYCredo Just Pulled Back—This Might Be the Cleanest Entry PointIn a semiconductor market rapidly approaching $1 trillion, a smaller player like Credo Technology Group Inc. (NASDAQ: CRDO)—which has a market capitalization of just $27.7 billion—is often overlooked. However, its high-speed, low-latency semiconductors and related products are increa…READ THE FULL STORYFINANCECash Is King: DigitalBridge Is the Ultimate Defensive PlayGlobal markets are currently navigating a minefield of uncertainty. Daily headlines about trade wars, shifting tariff policies, and violent price swings in the technology sector have left many investment portfolios exposed to sudden drops. In this volatile environment, the old financial adage &ldq…READ THE FULL STORYTECHNOLOGYWhy Taiwan Semiconductor and Meta Could Be the Hidden Bull Case for BroadcomAfter ending 2025 in a bad way, shares of semiconductor giant Broadcom (NASDAQ: AVGO) have continued to face pressure in 2026. Year-to-date, shares are down nearly 4%. Still, it is important to note that Broadcom isn’t alone in its weakness. Artificial intelligence (AI) processor stock NVI…READ THE FULL STORYBUSINESS SERVICESForget the Chips, Buy Memory: Why AI Money Is Moving to StorageWhile the stock market has spent the last two years obsessed with logic chips and GPUs, a significant shift is occurring in the hardware sector. The compute trade, which represents betting on the processors that allow AI models to think, is taking a breather. In its place, smart money is rotating …READ THE FULL STORYFRIDAY’S EARLY BIRD STOCK OF THE DAYA Stock With Insider Buying:SmartRent (NYSE:SMRT)SmartRent, Inc., an enterprise software company, provides an integrated smart home operating system to residential property owners and operators, homebuilders, institutional home buyers, developers, and residents in the United States. The company’s products and solutions include smart apartments and homes, access control for buildings, common areas, and rental units, asset protection and monitoring, parking management, self-guided tours, and community and resident Wi-Fi. It also offers professio…VIEW TODAY’S STOCK PICKThe Early Bird is a daily email newsletter powered by MarketBeat that covers the top stories that will impact the stock market each day. Read your copy every morning at 7:00 AM Eastern so that you can “catch the worm” when the market opens. View as a Web PageIf you have questions or concerns about your newsletter, don’t hesitate to contact MarketBeat’s U.S. based support team at contact@marketbeat.com. Unsubscribe Copyright 2006-2026 MarketBeat Media, LLC. All rights protected. 345 North Reid Place, Suite 620, Sioux Falls, SD 57103-7078. U.S.A..Just For You: 48-Hour Alert: This Signal Just Flashed on (TICKER) (Click to Opt-In)